CLBT Looks 26.6% Undervalued on GF Value™
Cellebrite DI Ltd (CLBT) announced its subsidiary achieved CMMC Level 2 certification. GF Value™ estimates CLBT is 26.6% undervalued at $12.01 vs. $16.36 intrinsic value. CLBT has a GF Score™ of 87, strong financials, and 11.2% 3-year revenue growth. Insiders sold $5.2M shares, while 5 gurus hold positions.
How this was made
The 30-second read
Why it matters
The article combines a new compliance certification with valuation commentary, offering limited actionable insight.
Market read
The certification news is modestly relevant; valuation discussion reinforces a potential buying case but lacks new material catalysts.
What to watch
Potential delays in contract negotiations and competition from larger defense IT providers.
Background
GuruFocus valuation metrics (GF Value, GF Score) are used to assess CLBT's undervaluation relative to its fundamentals.
Ticker impact
Cellebrite's subsidiary CFSI obtained CMMC Level 2 certification, a new compliance milestone that could enable future DoD contracts.
Potential modest upside as investors price in expanded addressable market.
The news is a fresh corporate development but limited in scale; impact depends on future contract awards.
Market effects
Highlights growing importance of cybersecurity compliance for defense contractors.
U.S. defense and cybersecurity sectors may see modest interest.
Limited to firms seeking DoD contracts; not a broad market driver.
Counterpoint
Certification alone may not translate to contracts; revenue impact could be minimal.
Key entities
- CompanyCellebrite DI Ltd
Provider of digital investigative solutions, ticker CLBT.
- SubsidiaryCellebrite Federal Solutions Inc.
Achieved CMMC Level 2 certification.



